Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the activity of nerispirdine in improving the ability to
walk, in patients with multiple sclerosis (MS).
Secondary objectives:
- To assess other measures of walking ability, tiredness, and lower limb muscular
strength, spasticity, clinical assessment by subject and clinical assessment of change
by the Study Investigator
- To assess the safety and tolerance of nerispirdine
- To evaluate the pharmacokinetics (PK) parameters of nerispirdine